Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts

International Immunopharmacology

Volumn 7, Issue 6, 2007, Pages 816-823

  Liu, Ji Yong ^a   Hu, Jin Hong ^a   Zhu, Quan Gang ^a   Li, Feng Qian ^a   Wang, Jing ^a   Sun, Hua Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cutaneous inflammation; Cytokines; Fibroblast; HaCaT cell line; Matrine; Substance P receptor

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROKININ 1 RECEPTOR; SUBSTANCE P RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DISEASE;

ALKALOIDS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; FIBROBLASTS; HUMANS; KERATINOCYTES; QUINOLIZINES; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 34247376897     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.02.003     Document Type: Article

References (44)

1. Luger T.A. Neuromediators-a crucial component of the skin immune system. J Dermatol Sci 30 (2002) 87-93
2. O'Sullivan R.L., Lipper G., and Lerner E.A. The neuro-immuno-cutaneous-endocrine network: relationship of mind and skin. Arch Dermatol 134 (1998) 1431-1435
3. Kyu H.K., Kyoung C.P., Jin H.C., and Hae R.C. The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32 (2003) 115-124
4. Seiffert K., and Granstein R.D. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 28 (2002) 97-103
5. Staniek V., Doutremepuich J.D., Schmitt D., Claudy A., and Misery L. Expression of substance P receptors in normal and psoriatic skin. Pathobiology 67 (1999) 51-54
6. Quartara L., and Maggi C.A. The tachykinin NK-1 receptor. Part II: distribution and pathaphysiological roles. Neuropeptides 32 (1998) 1-49
7. Stanisz A.M., Scicchitano R., Dazin P., Bienenstock J., and Payan D.G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 139 (1987) 749-754
8. Lucey D.R., Novak J.M., Polonis V.R., Liu Y., and Gartner S. Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol 1 (1994) 330-335
9. Shanahan F., Denburg J.A., Fox J., Bienenstock J., and Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135 (1985) 1331-1337
10. Marriott I., and Bost K.L. Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 114 (2001) 131-141
11. Lai J., Douglas S.D., and Ho W.Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol 86 (1998) 80-86
12. Liu J.Y., Hu J.H., Zhu QG., Li F.Q., and Sun H.J. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol 155 (2006) 657-662
13. Tan H.R., and Zhang B.H. Experimental study of the anti-inflammatory effect of matrine. Zhong Xi Yi Jie He Za Zhi 5 (1985) 108-109
14. Hu Z.L., Zhang J.P., Qian D.H., Lin W., Xie W.F., Zhang X.R., et al. Effect of matrine on mouse splenocyte proliferation and release of interleukin-1 and -6 from peritoneal macrophages in vitro. Acta Pharmacol Sin 17 (1996) 259-261
15. Luo Y.X., Zhang X.M., Gao W., and Wu Q.F. Studies on site of analgesic action of matrine and its mechanism. Chin Trad Herbal Drugs 32 (2001) 41-43
16. Xu C.Q., Dong D.L., Du Z.M., Chen Q.W., Gong D.M., and Yang B.F. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866. Acta Pharm Sin 39 (2004) 691-694
17. Deng H., Luo H., Huang F., Li X., and Gao Q. Inhibition of proliferation and influence of proto-oncogenes expression by matrine in C6 cell. Zhong Yao Cai 27 (2004) 416-419
18. Xin S.M., and Ma Z.Q. Anti-diarrhea effect of matrine. Chin Trad Patent Med 20 (1998) 30-32
19. Pei R.J., Xiao L., Fan X.P., and Liu X.J. The effects of matrine on mouse immune functions. Hai Xia Yao Xue 10 (1998) 7-8
20. Lin W., Zhang J.P., Hu Z.L., and Qian D.H. Inhibitory effect of matrine on lipopolysacchride-induced tumor necrosis factor and interleukin-6 production from rat Kupffer cells. Acta Pharm Sin 32 (1997) 93-96
21. Zhang L.P., Jiang J.K., Tam J.W.O., Zhang Y., Liu X.S., et al. Effects of matrine on proliferation and differentiation in K-562 cells. Leuk Res 25 (2001) 793-800
22. Cheng H., Xia B., Zhang L., Zhou F., Zhang Y.X., Ye M., et al. Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Pharmacol Res 53 (2006) 202-208
23. Zhang J.P., Zhang M., Jin C., Zhou B., Xie W.F., Guo C., et al. Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin 22 (2001) 765-768
24. Wu Y.A., and Gao C.F. Matrine inhibits proliferation of mouse skin fibroblasts induced by platelet-derived growth factor-BB. Pharm J Chin PLA 16 (2000) 132-134
25. Kis K., Bodai L., Polyanka H., Eder K., Pivarcsi A., Duda E., et al. Budesnide, but not tacrolimus, affects the immune functions of mormal human keratinocytes. Int Immunopharmacol 6 (2006) 358-368
26. Welss T., Basketter D.A., and Schroder K.R. In vitro skin irritation: facts and future. State of the art review of mechanism and models. Toxicol in Vitro 18 (2004) 231-243
27. Matsuura K., Otsuka F., and Fujisawa H. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes. Cytokine 10 (1998) 500-505
28. Kohda F., Koga T., Uchi H., Urabe K., and Furue M. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes. J Dermatol Sci 28 (2002) 34-41
29. Engelhart K., El Hindi T., Biesalski H.-K., and Pfitaner I. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res 297 (2005) 1-9
30. Gibran N.S., Ferguson M., Heimbach D.M., and Isik F.F. Monocyte chemotactic protein-1 expression in the human burn wound. J Surg Res 70 (1997) 1-6
31. Padwad Y., Ganju L., Jain M., Chanda S., Karan D., Banerjee P.K., et al. Effect of leaf extract of Seabuckthorn on lipoplysaccharide induced inflammatory response in murine macrophages. Int Immunopharmacol 6 (2006) 46-52
32. Watanabe M., Nakayasu K., Iwatsu M., and Kanai A. Endogenous substance P in corneal epithelial cell and keratocytes. Jpn J Ophthalmol 46 (2002) 616-620
33. Staniek V., Liebich C., Vocks E., Qdia S.G., Doutremepuich J.D., Ring J., et al. Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation. Acta Derm Venereol 78 (1998) 92-94
34. Lotz K., Vaughall D., and Carson D. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241 (1988) 1218-1220
35. Kiss M., Kemeny L., Gyulai R., Michel G., Husz S., Kovacs R., et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide and alpha-melanocyte-stimulating hormone on the IL-8/IL-8 receptor system in a cultured human keratinocyte cell and dermal fibroblasts. Inflammation 23 (1999) 557-567
36. Kupper T.S., and Groves R.W. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 105 (1995) 62-66
37. Larsen C.G., Anderson A.O., Appella E., Oppenheim J.J., and Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotatic for T lymphocytes. Science 243 (1989) 1464-1466
38. Kemeny L., Kenderessy A.S., Olasz E., Michel G., Ruzicka T., Farkas B., et al. The interleukin-8 receptor: a potential target for antipsoriatic therapy. Eur J Pharmacol 258 (1994) 269-272
39. Gitter B.D., Regoli D., Howbert J.J., Glasebrook A.L., and Waters D.C. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol 51 (1994) 101-108
40. Spangelo B.L., Isakson P.C., and MacLeod R.M. Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology 127 (1990) 403-409
41. Kupper T.S., Min K., Sehgal P., Mizutani H., Birchall N., Ray A., et al. Production of IL-6 by keratinocytes: implication of epidermal inflammation and immunity. Ann N Y Acad Sci 557 (1989) 454-464
42. Christensen P.J., Rolfe M.W., Standiford T.J., Burdick M.D., Toews G.B., and Strieter R.M. Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response. J Immunol 151 (1993) 1205-1213
43. Gillitzer R., Wolff K., Tong D., Muller C., Yoshimura T., Hartmann A.A., et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101 (1993) 127-131
44. Sasaki T., Kano R., Sato H., Nakamura Y., Watanabe S., and Hasegawa A. Effect of staphylococci on cytokine production from human keratinocytes. Br J Dermatol 148 (2003) 46-50